Siddiqui Asim A, Bora Hema, Singh Neeru, Dash Aditya P, Sharma Yagya D
Department of Biotechnology, All India Institute of Medical Sciences, New Delhi 110029, India.
Infect Immun. 2008 Jun;76(6):2576-86. doi: 10.1128/IAI.00677-07. Epub 2008 Mar 24.
We describe here an approximately 40-kDa Plasmodium vivax tryptophan-rich antigen (PvTRAg40) which contains 321 amino acids and 11.4% tryptophan residues. This protein shows 65% homology (35% identity) with the previously described PvTRAg, besides sharing 23 of 27 positionally conserved tryptophan residues and similar genomic organization. The nucleotide sequence of the entire tryptophan-rich domain of PvTRAg40 was identical among 35 P. vivax clinical isolates. The protein is expressed by ring, trophozoite, and schizont stages of the parasite. The cDNA covering exon 2 of PvTRAg40 was cloned and expressed in the pPROEXHTa vector, and recombinant protein was purified. A high humoral immune response (90.7% seropositivity; n = 43) against this recombinant protein was detected in humans during the course of natural P. vivax infection. Eighty percent of the total of 20 P. vivax-exposed individuals exhibited lymphoproliferative responses against this antigen. The T cells of these individuals produced larger amounts of interleukin-12 (IL-12), IL-4, and IL-10 than gamma interferon and tumor necrosis factor alpha cytokines in response to the recombinant protein. Production of Th2-biased cytokines, conserved T- and B-cell epitopes, and an enhanced humoral immune response indicate that PvTRAg40 could possibly induce antibody-mediated immune protection against infection.
我们在此描述一种约40 kDa的间日疟原虫富含色氨酸抗原(PvTRAg40),它含有321个氨基酸,色氨酸残基占11.4%。除了27个位置保守的色氨酸残基中有23个相同以及基因组组织相似外,该蛋白与先前描述的PvTRAg有65%的同源性(35%的一致性)。PvTRAg40富含色氨酸结构域的核苷酸序列在35个间日疟原虫临床分离株中是相同的。该蛋白在疟原虫的环状体、滋养体和裂殖体阶段表达。覆盖PvTRAg40外显子2的cDNA被克隆并在pPROEXHTa载体中表达,重组蛋白被纯化。在间日疟原虫自然感染过程中,在人类中检测到针对这种重组蛋白的高体液免疫反应(血清阳性率为90.7%;n = 43)。在20个接触过间日疟原虫的个体中,80%对该抗原有淋巴细胞增殖反应。这些个体的T细胞在对重组蛋白的反应中产生的白细胞介素-12(IL-12)、IL-4和IL-10比γ干扰素和肿瘤坏死因子α细胞因子更多。Th2偏向性细胞因子的产生、保守的T细胞和B细胞表位以及增强的体液免疫反应表明,PvTRAg40可能诱导抗体介导的针对感染的免疫保护。